76 related articles for article (PubMed ID: 2852604)
1. Oral N-acetylcysteine reduces selected humoral markers of inflammatory cell activity in BAL fluid from healthy smokers: correlation to effects on cellular variables.
Eklund A; Eriksson O; Håkansson L; Larsson K; Ohlsson K; Venge P; Bergstrand H; Björnson A; Brattsand R; Glennow C
Eur Respir J; 1988 Oct; 1(9):832-8. PubMed ID: 2852604
[TBL] [Abstract][Full Text] [Related]
2. The eosinophil component of the alveolitis in idiopathic pulmonary fibrosis. Signs of eosinophil activation in the lung are related to impaired lung function.
Hällgren R; Bjermer L; Lundgren R; Venge P
Am Rev Respir Dis; 1989 Feb; 139(2):373-7. PubMed ID: 2536526
[TBL] [Abstract][Full Text] [Related]
3. [Diagnostic value of secretory products of eosinophils and neutrophils in bronchoalveolar lavage in patients with idiopathic lung fibrosis].
Pohl WR; Schenk E; Umek H; Micksche M; Kummer F; Köhn H
Wien Klin Wochenschr; 1993; 105(14):387-92. PubMed ID: 8396288
[TBL] [Abstract][Full Text] [Related]
4. Effects of oral N-acetylcysteine on cell content and macrophage function in bronchoalveolar lavage from healthy smokers.
Linden M; Wieslander E; Eklund A; Larsson K; Brattsand R
Eur Respir J; 1988 Jul; 1(7):645-50. PubMed ID: 2846345
[TBL] [Abstract][Full Text] [Related]
5. Granulocytes and their secretory products, myeloperoxidase and eosinophil cationic protein, in bronchoalveolar lavage fluids from two lung lobes in normal subjects.
Schmekel B; Blom-Bülow B; Hörnblad Y; Laitinen LA; Linden M; Venge P
Eur Respir J; 1991 Jul; 4(7):867-71. PubMed ID: 1659539
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil-associated activation markers in healthy smokers relates to a fall in DL(CO) and to emphysematous changes on high resolution CT.
Ekberg-Jansson A; Andersson B; Bake B; Boijsen M; Enanden I; Rosengren A; Skoogh BE; Tylén U; Venge P; Löfdahl CG
Respir Med; 2001 May; 95(5):363-73. PubMed ID: 11392577
[TBL] [Abstract][Full Text] [Related]
7. Kinetic retrieval of eosinophil cationic protein, hyaluronan, secretory IgA, albumin, and urea during BAL in healthy subjects.
Schmekel B; Hörnblad Y; Hvatum M; Norlund AL; Venge P
Chest; 1995 Jul; 108(1):62-7. PubMed ID: 7606993
[TBL] [Abstract][Full Text] [Related]
8. Effects of oral administration of N-acetyl-L-cysteine: a multi-biomarker study in smokers.
Van Schooten FJ; Besaratinia A; De Flora S; D'Agostini F; Izzotti A; Camoirano A; Balm AJ; Dallinga JW; Bast A; Haenen GR; Van't Veer L; Baas P; Sakai H; Van Zandwijk N
Cancer Epidemiol Biomarkers Prev; 2002 Feb; 11(2):167-75. PubMed ID: 11867504
[TBL] [Abstract][Full Text] [Related]
9. Airway inflammation in smokers with nonobstructive and obstructive chronic bronchitis.
Linden M; Rasmussen JB; Piitulainen E; Tunek A; Larson M; Tegner H; Venge P; Laitinen LA; Brattsand R
Am Rev Respir Dis; 1993 Nov; 148(5):1226-32. PubMed ID: 8239158
[TBL] [Abstract][Full Text] [Related]
10. The distribution of myeloperoxidase, eosinophil cationic protein, albumin and urea in sequential bronchoalveolar lavage.
Schmekel B; Venge P
Eur Respir J; 1991 May; 4(5):517-23. PubMed ID: 1657631
[TBL] [Abstract][Full Text] [Related]
11. Activation of eosinophils and fibroblasts assessed by eosinophil cationic protein and hyaluronan in BAL. Association with acute rejection in lung transplant recipients.
Riise GC; Scherstén H; Nilsson F; Ryd W; Andersson BA
Chest; 1996 Jul; 110(1):89-96. PubMed ID: 8681673
[TBL] [Abstract][Full Text] [Related]
12. Influence of personal factors on nasal patency and lavage biomarkers in white-collar workers.
Wålinder R; Wieslander G; Norbäck D; Erwall C; Venge P
Rhinology; 2000 Sep; 38(3):130-5. PubMed ID: 11072659
[TBL] [Abstract][Full Text] [Related]
13. Fecal lactoferrin as a marker for disease activity in inflammatory bowel disease: comparison with other neutrophil-derived proteins.
Sugi K; Saitoh O; Hirata I; Katsu K
Am J Gastroenterol; 1996 May; 91(5):927-34. PubMed ID: 8633583
[TBL] [Abstract][Full Text] [Related]
14. Cell specific markers for eosinophils and neutrophils in sputum and bronchoalveolar lavage fluid of patients with respiratory conditions and healthy subjects.
Metso T; Venge P; Haahtela T; Peterson CG; Sevéus L
Thorax; 2002 May; 57(5):449-51. PubMed ID: 11978925
[TBL] [Abstract][Full Text] [Related]
15. Lactoferrin in whole gut lavage fluid as a marker for disease activity in inflammatory bowel disease: comparison with other neutrophil-derived proteins.
Kayazawa M; Saitoh O; Kojima K; Nakagawa K; Tanaka S; Tabata K; Matsuse R; Uchida K; Hoshimoto M; Hirata I; Katsu K
Am J Gastroenterol; 2002 Feb; 97(2):360-9. PubMed ID: 11866274
[TBL] [Abstract][Full Text] [Related]
16. The predictive and discriminative value of biologically active products of eosinophils, neutrophils and complement in bronchoalveolar lavage and blood in patients with adult respiratory distress syndrome.
Modig J; Samuelsson T; Hällgren R
Resuscitation; 1986 Nov; 14(3):121-34. PubMed ID: 3027805
[TBL] [Abstract][Full Text] [Related]
17. Serum ECP and MPO are increased during exacerbations of chronic bronchitis with airway obstruction.
Fiorini G; Crespi S; Rinaldi M; Oberti E; Vigorelli R; Palmieri G
Biomed Pharmacother; 2000 Jun; 54(5):274-8. PubMed ID: 10917466
[TBL] [Abstract][Full Text] [Related]
18. Glutathione in bronchoalveolar lavage fluid from smokers is related to humoral markers of inflammatory cell activity.
Linden M; Håkansson L; Ohlsson K; Sjödin K; Tegner H; Tunek A; Venge P
Inflammation; 1989 Dec; 13(6):651-8. PubMed ID: 2613293
[TBL] [Abstract][Full Text] [Related]
19. Serum eosinophilic cationic protein and lactoferrin related to smoking history and lung function.
Jensen EJ; Pedersen B; Schmidt E; Venge P; Dahl R
Eur Respir J; 1994 May; 7(5):927-33. PubMed ID: 8050550
[TBL] [Abstract][Full Text] [Related]
20. The side-effects of cardiopulmonary bypass on the lungs: changes in bronchoalveolar lavage fluids.
Alat I; Yüksel M; Büket S; Nalbantgil S; Aşkar F; Bayindir U; Taşbakan S; Kokuludag A; Veral A
Perfusion; 2001 Mar; 16(2):121-8. PubMed ID: 11334195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
